Facebook Linkedin Soundcloud Twitter Vimeo Xing
Home Tags ISAC

Tag: ISAC

Ex Vivo Data Support the High Frequency of Myeloid Cells in...

ADC Review | Editorial Team
Historically, Immuno-oncology has focused on T cell-driven effects. However, a growing class of myeloid therapies including immune-stimulating antibody conjugates or ISACs, which comprise a...

Piramal Pharma Solutions and Bolt Biotherapeutics Sign Production Agreement

ADC Review | Editorial Team
Piramal Pharma Solutions, a contract development and manufacturing organization (CDMO) and San Francisco-based biotech Bolt Bioterapeutics have signed a production agreement in which Piramal...
The AACR 2019 Annual Meeting - Poster Session during the American Association for Cancer Research (AACR) Annual Meeting, Sunday March 31, 2019. Courtesy: © AACR/Todd Buchanan 2019

Randall Schatzman, Ph.D. to Lead Growth of Immune-Stimulating Antibody Conjugates at...

Peter Hofland
Veteran Executive Randall Schatzman, Ph.D. has been hired as the new Chief Executive Officer and a member of the board of directors of Bolt...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.

X